Mass spectrometry raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-08-07 and is reviewed periodically as new material appears.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human therapeutic use | No marketing authorization identified in major jurisdictions. |
| Anti-doping class | PPARδ agonist; hormone and metabolic modulators | Listed on the WADA Prohibited List. |
| Common test matrix | Urine | Also blood and tissue in research settings. |
| Typical analytical method | LC-MS/MS | Targets parent compound and metabolites. |
| Major safety signal | Tumor findings in rodents | Human relevance not established; limited human data. |
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
==== Mammalian studies ==== Studies conducted in rats have indicated that their degree of sexual arousal is sensitive to reductions in testosterone. When testosterone-deprived rats were given medium levels of testosterone, their sexual behaviors (copulation, partner preference, etc.) resumed, but not when given low amounts of the same hormone. Therefore, these mammals may provide a model for studying clinical populations among humans with sexual arousal deficits such as hypoactive sexual desire disorder. Every mammalian species examined demonstrated a marked increase in a male's testosterone level upon encountering a novel female. The reflexive testosterone increases in male mice is related to the male's initial level of sexual arousal. In non-human primates, it may be that testosterone in puberty stimulates sexual arousal, which allows the primate to increasingly seek out sexual experiences with females and thus creates a sexual preference for females. Some research has also indicated that if testosterone is eliminated in an adult male human or other adult male primate's system, its sexual motivation decreases, but there is no corresponding decrease in ability to engage in sexual activity (mounting, ejaculating, etc.). In accordance with sperm competition theory, testosterone levels are shown to increase as a response to previously neutral stimuli when conditioned to become sexual in male rats.
pre-formulation, formulation development, stability studies, method development, pre-clinical and Phase I clinical trial materials, late-stage clinical trial materials, formal stability, scale-up, registration batches and commercial production. CDMOs are contract manufacturers, yet they provide development as a standard part of their services. Their customers are not only expecting competitive pricing, but also regulatory compliance, flexibility on the production capability and on-time delivery. Overall it is required that CMO complies with good manufacturing practice from their client and regulatory bodies such as the Food and Drug Administration.
Unlike most modern eggs, many non-avian dinosaur eggs had a rough texture formed by nodes and ridges ornamenting the surface of their shell. This is predominant in Cretaceous dinosaur eggs, but very rare in eggs from the Jurassic or Triassic. Because of the lack of modern analogues, the purpose of eggshell ornamentation is unknown, but many functions have been proposed. Possibly, they provided extra strength to the eggshell without having pore canals too long for adequate gas exchange. They could also have helped keep substrate away from the pore openings of eggs that were buried, but modern turtles and crocodylians which bury their eggs have smooth eggshells, so this adaptation is not necessary for animals which bury their eggs. Another hypothesis, proposed by R. M. Mellon in 1982 in his senior thesis at Princeton University, is that the ridges and nodes would have formed pathways for gas to flow across the surface of the eggshell, preventing accumulation of too much CO2 and aiding the flow of oxygen and water vapor. Since it varies from egg to egg, the texture of an eggshell's ornamentation is useful for classification. Six types of ornamentation were catalogued by Carpenter in 1999:
Sources: en.wikipedia.org
==== Silver mirror reaction ==== The silver mirror reaction involves the conversion of silver nitrate to Ag(NH3)OH. Ag(NH3)OH is subsequently reduced into colloidal silver using an aldehyde containing molecule such as a sugar. The silver mirror reaction is as follows:
The intervention of the United States was due to two distinct causes; a territorial annexation and a revolts within the Spanish territories itself. The Republic of West Florida was a short-lived republic in 1810 in the westernmost region of Spanish West Florida, which after less than three months was annexed and occupied by the United States a little later in 1810, and then became part of the territory of Louisiana. The Republic of East Florida was another republic declared against Spanish rule of East Florida by insurgents who wanted its annexation by the United States without success. In 1819, the Treaty of Florida was signed between Spain and the United States, and Spain ceded all of Florida to the United States. In 1811, the Spanish crushed the San Antonio (Texas) revolt during the revolution against the royalists in the Mexican War of Independence. The remaining rebels then turned to the United States for help. Bernardo Gutiérrez de Lara traveled to Washington, D.C. Gutierrez gained the support of Augustus Magee and formed a U.S. filibuster force in Louisiana. A green flag from the expedition represented the rebels. The Northern Republican Army was defeated in the bloodiest battle in Texas, the Battle of Medina. Thus, Texas was incorporated into the Mexican Independence, and later Texas Independence and its annexation to the United States took place. The United States remained neutral. Thus, for the rest of Madison's term, until 1817, a theoretical United States neutrality held pending the development of events in the Old World.
Military tension between the two countries in the Kargil district led to the Kargil War of 1999, and turmoil in civil-military relations allowed General Pervez Musharraf to take over through a bloodless coup d'état. Musharraf governed Pakistan as chief executive from 1999 to 2002 and as president from 2001 to 2008—a period of enlightenment, social liberalism, extensive economic reforms, and direct involvement in the US-led war on terrorism. By its own financial calculations, Pakistan's involvement in the war on terrorism has cost up to $118 billion, over eighty one thousand casualties, and more than 1.8 million displaced civilians. The National Assembly historically completed its first full five-year term on 15 November 2007. After the assassination of Benazir Bhutto in 2007, the PPP secured the most votes in the elections of 2008, appointing party member Yusuf Raza Gilani as Prime Minister. Threatened with impeachment, President Musharraf resigned on 18 August 2008, and was succeeded by Asif Ali Zardari. Clashes with the judicature prompted Gilani's disqualification from the Parliament and as the prime minister in June 2012. The general election held in 2013 saw the PML (N) achieve victory, following which Nawaz Sharif was elected as Prime Minister for the third time. In 2018, PTI won the general election and Imran Khan became the 22nd Prime Minister. In April 2022, Shehbaz Sharif was elected as prime minister, after Imran Khan lost a no-confidence vote.
=== Other === Flunitrazepam impairs cognitive functions. This may appear as lack of concentration, confusion and anterograde amnesia—the inability to create memories while under the influence. It can be described as a hangover-like effect which can persist to the next day. It also impairs psychomotor functions similar to other benzodiazepines and nonbenzodiazepine hypnotic drugs; falls and hip fractures were frequently reported. The combination with alcohol increases these impairments. Partial, but incomplete tolerance develops to these impairments. Other adverse effects include:
Sources: en.wikipedia.org
== Role of smoking == To date, all reported patients with SRIF have been heavy current smokers or ex-smokers, lending credence to the assertion that this condition is caused by smoking. There are no published reports of SRIF in never-smokers.
and Canada that contain aspartame must be labeled: "Phenylketonurics: Contains phenylalanine." In the UK, foods containing aspartame must carry ingredient panels that refer to the presence of "aspartame or E951" and they must be labeled with a warning "Contains a source of phenylalanine." In Brazil, the label "Contém Fenilalanina" (Portuguese for "Contains Phenylalanine") is mandatory in products which contain it. These warnings are placed to help individuals avoid such foods.
== Early years == Rodrigo Roa Duterte was born on March 28, 1945, in Maasin, Leyte. His father was Vicente Gonzales Duterte (1911–1968), a Cebuano lawyer, and his mother, Soledad Gonzales Roa (1916–2012), was a schoolteacher from Cabadbaran, Agusan and a civic leader, of Chinese and Spanish mestizo descent. Duterte has said that his grandfather was Chinese and hailed from Xiamen in Fujian, China. Duterte has four siblings: Eleanor (born 1941/42), Emmanuel, Jocelyn (1948–2023) and Benjamin ("Bong", 1953–2026). Duterte's father was mayor of Danao, Cebu, and subsequently the provincial governor of (the then-undivided) Davao province. Rodrigo's cousin Ronald was mayor of Cebu City from 1983 to 1986. Ronald's father, Ramon Duterte, also held that position from 1957 to 1959. The Dutertes consider the Cebu-based political families of the Durano and the Almendras clan as relatives. Duterte also has relatives from the Roa clan in Leyte through his mother's side. Duterte's family lived in Maasin, and in his father's hometown in Danao, until he was four years old. Duterte was heavily influenced by his mother, who unlike Vicente was a staunch anti-Marcos activist, which led the young Duterte to have a divided opinion on the Marcoses. Duterte later said Marcos could have been the best president, but he was a dictator. The Dutertes initially moved to Mindanao in 1948 but still went back and forth to the Visayas until 1949. They finally settled in the Davao Region in 1950. Vicente worked as a lawyer engaged in private practice.
Sources: en.wikipedia.org
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.
It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.
Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.
Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.